Corticosteroids and beta adrenergic agonists innormal subjects.
作者信息
Tattersfield A E, Holgate S T
出版信息
Acta Tuberc Pneumol Belg. 1977 Jan-Mar;68(1):75-8.
PMID:22227
Abstract
摘要
相似文献
1
Corticosteroids and beta adrenergic agonists innormal subjects.正常受试者中的皮质类固醇和β-肾上腺素能激动剂。
Acta Tuberc Pneumol Belg. 1977 Jan-Mar;68(1):75-8.
2
[Effect of corticosteroids on the action of sympathomimetics].[皮质类固醇对拟交感神经药作用的影响]
Bull Eur Physiopathol Respir. 1985 Sep-Oct;21(5):53s-55s.
3
Long acting beta agonists.
Aust Fam Physician. 1998 Dec;27(12):1115-8.
4
Beta 2-agonists and corticosteroids: new developments and controversies. Report of a meeting in November 1990.β2 激动剂与皮质类固醇：新进展与争议。1990年11月一次会议的报告。
Am Rev Respir Dis. 1992 Dec;146(6):1637-41. doi: 10.1164/ajrccm/146.6.1635.
5
Long-acting beta agonists--prescribe with care.长效β受体激动剂——谨慎开具处方。
N Z Med J. 2006 Jul 7;119(1237):U2064.
6
Safety of long-acting beta-agonists.长效β受体激动剂的安全性
N Engl J Med. 2006 Mar 16;354(11):1206-8; author reply 1206-8.
7
FDA offers advice to reduce risks of long-acting beta-agonists in asthma care.美国食品药品监督管理局提供建议以降低哮喘治疗中长效β受体激动剂的风险。
JAMA. 2010 Apr 14;303(14):1353-4. doi: 10.1001/jama.2010.357.
8
Management of difficult asthma.难治性哮喘的管理
Br J Hosp Med. 1994;51(3):80-1.
9
10
Combination inhalers containing inhaled corticosteroids and long-acting beta2-agonists: improved clinical efficacy and dosing options in patients with asthma.含有吸入性皮质类固醇和长效β2受体激动剂的联合吸入器：改善哮喘患者的临床疗效和给药选择。
J Asthma. 2005 Nov;42(9):715-24. doi: 10.1080/02770900500305748.
Zotero 插件